Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Expert Panel Calls For More Trials And Restricted Clinical Use In Latest Cardiology Device Opinion

Executive Summary

A European Commission medical devices expert panel which specializes in the circulatory system has once again challenged the data that has been submitted by a manufacturer of a high-risk medical device to a notified body.

You may also be interested in...



Five Key Meetings Offering EU Medtech Regulatory Insights Over Next Four Months

With so many regulatory developments happening concurrently in the EU at present, five forthcoming conferences promise delegates a timely update and vibrant discussions.

Implementing The MDR And IVDR: Checkered History Signposts Need For Revised Approach

With so much discussion now on the need for fundamental change in the future regulation of medtech products in the EU, Medtech Insight reflects on lessons to be learnt.

Medtech Industry Produces Evidence In Bid For Updated eIFU Rules In Multilingual EU Marketplace

The EU medtech industry is calling for an update to the decades-old rules on electronic IFU for devices. A glimpse at the listings in the European Commission’s recently released table of member state language requirements reflects how punitive the demand for hard-copy IFU can be.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147694

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel